Errata - English

Line 3: Change
As a minimum, the analytical procedure should be assessed by performing the repeatability test in any of the conditions previously mentioned (totaling 12 measurements).
to:
As a minimum, the analytical procedure should be assessed by performing the repeatability test in any combination of at least two of the conditions previously mentioned (totaling 12 measurements).

Line 1 of Physicochemical Tests/Acidity or Alkalinity/BRP indicator solution: Change
1.0 mg/mL of bromophenol blue,
to:
1.0 mg/mL of bromothymol blue,
AND
Line 3 of Plastic Additives/Polyethylene, Cyclic Olefins, and Polypropylene/Phenolic Antioxidants/Test B: Change
tris(2,4-di-tert-butylphenyl) phosphate;
to:
tris(2,4-di-tert-butylphenyl) phosphite;
AND
Line 1 of Plastic Additives/Polyethylene, Cyclic Olefins, and Polypropylene/Phenolic Antioxidants/Test C/Mobile phase: Change
(55:45:5, v/v/v)
to:
(50:45:5, v/v/v)
AND
Line 1 of Plastic Additives/Polyethylene, Cyclic Olefins, and Polypropylene/Nonphenolic Antioxidants/Chromatographic system/Application: Change
20 µL of Sample solution S10, reference solution (o) and the reference solutions corresponding to
to:
20 µL of Sample solution S10 and the reference solutions corresponding to
AND
Line 2 of Plastic Additives/Plasticized Polyvinyl Chloride/USP Reference Standards <11>/USP Plastic Additive 05 RS: Change
Tris(2,4-di-tert-butylphenyl) phosphate.
to:
Tris(2,4-di-tert-butylphenyl) phosphite.  

Line 1 of Plastic Additives/Reference solutions/Reference solution I: Change
0.24 mg/mL of USP Plastic Additive 4 RS prepared in the Solvent mixture
to:
0.24 mg/mL of USP Plastic Additive 4 RS prepared in methylene chloride
AND
Line 1 of Reference solution J: Change
0.24 mg/mL of USP Plastic Additive 5 RS prepared in the Solvent mixture
to:
0.24 mg/mL of USP Plastic Additive 5 RS prepared in methylene chloride
AND
Line 1 of Poly(ethylene-vinyl acetate)/Polyvinyl chloride, plasticized/Reference solutions U, V, W: Change
0.1-mg/mL solutions
to:
10.0-mg/mL solutions

In Aflatoxin standard solution: Change
ε = molecular absorptivity
to:
ε = molar absorptivity
AND
in paragraph 2 of Aflatoxin standard solution: Change
transfer an accurate volume of each aflatoxin standard stock solution
to:
transfer an accurate volume of each aflatoxin stock solution

Line 3 of Flow Rate (HPLC): Change

in which F₁ is the flow rate indicated in the monograph, in mL/min; F₂ is the adjusted flow rate, in mL/min; l₁ is the length of the column indicated in the monograph; l₂ is the length of the column used; d₁ is the column inner diameter indicated in the monograph; and d₂ is the internal diameter of the column used. Additionally, the flow rate can be adjusted by ±50%.
to:

in which F₁ is the flow rate indicated in the monograph, in mL/min; F₂ is the adjusted flow rate, in mL/min; d₁ is the column inner diameter indicated in the monograph; and d₂ is the internal diameter of the column used. Additionally, the flow rate can be adjusted by ±50%.

Line 1 of Vitamin A, Method 1/Sample solution: Change
Sample solution
to:
Sample stock solution
AND
Line 23 of Sample solution: Change
Dilute a volume of this solution
to:
Sample solution: Dilute a volume of the Sample stock solution
AND
Line 1 of Cholecalciferol or Ergocalciferol (Vitamin D), Method 1/Sample solution:Change
Proceed as directed for the Sample solution
to:
Proceed as directed for the Sample stock solution
AND
Line 1 of Vitamin E, Method 1/Sample solution: Change
Proceed as directed for the Sample solution
to:
Proceed as directed for the Sample stock solution
AND
Line 2 of Phytonadione/Sample solution:Change
in the directions for the Sample solution
to:
in the directions for the Sample stock solution

Line 1 of Vitamin A, Method 1/Sample solution: Change
Sample solution
to:
Sample stock solution
AND
Line 16 of Sample solution: Change
Dilute a 10-mL volume of this solution
to:
Sample solution: Dilute a 10-mL volume of the Sample stock solution
AND
Line 1 of Cholecalciferol or Ergocalciferol (Vitamin D), Method 1/Sample solution: Change
Proceed as directed for the Sample solution
to:
Proceed as directed for the Sample stock solution
AND
Line 1 of Vitamin E, Method 1/Sample solution: Change
Proceed as directed for the Sample solution
to:
Proceed as directed for the Sample stock solution
AND
Line 2 of Phytonadione, Method 1/Sample solution: Change
retained as specified in the directions for the Sample solution
to:
retained as specified in the directions for the Sample stock solution

Line 1 of Vitamin A, Method 1/Sample solution: Change
Sample solution
to:
Sample stock solution
AND
Line 23 of Vitamin A, Method 1/Sample solution: Change
Dilute a volume of this solution
to:
Sample solution: Dilute a volume of the Sample stock solution
AND
Line 2 of Cholecalciferol or Ergocalciferol (Vitamin D), Method 1/Sample solution:Change
prepared as directed for the Sample solution
to:
prepared as directed for the Sample stock solution
AND
Line 2 of Vitamin E, Method 1/Sample solution:Change
prepared as directed for the Sample solution
to:
prepared as directed for the Sample stock solution
AND
Line 2 of Phytonadione:Change
prepared as directed for the Sample solution
to:
prepared as directed for the Sample stock solution

Line 1 of Vitamin A, Method 1/Sample solution: Change
Sample solution
to:
Sample stock solution
AND
Line 16 of Sample solution: Change
Dilute a 10-mL volume of this solution
to:
Sample solution: Dilute a 10-mL volume of the Sample stock solution
AND
Line 2 of Cholecalciferol or Ergocalciferol (Vitamin D), Method 1/Sample solution: Change
prepared as directed for the Sample solution
to:
prepared as directed for the Sample stock solution
AND
Line 2 of Vitamin E, Method 1/Sample solution: Change
prepared as directed for the Sample solution
to:
prepared as directed for the Sample stock solution
AND
Line 2 of Phytonadione, Method 1/Sample solution: Change
prepared as directed for the Sample solution
to:
prepared as directed for the Sample stock solution

In the variable definition for F in Vitamin E, Method 2/Analysis: Change
1/2 for products labeled to contain all-rac vitamin E sources)
to:
1/2 (for products labeled to contain all-rac vitamin E sources)
AND
In Biotin, Method 2/Basal medium stock solution: Change
Dissolve the anhydrous dextrose and anhydrous Sodium acetate
to:
Dissolve the anhydrous dextrose and anhydrous sodium acetate
AND
In Cyanocobalamin, Method 2/Basal medium stock solution: Change
thedextros,
to:
the dextrose,
AND
In the Calculate statement in Niacin or Niacinamide, Pyridoxine Hydrochloride, Riboflavin, and Thiamine, Method 1/Analysis: Delete
, calcium pantothenate (C₁₈H₃₂CaN₂O₁₀), and folic acid (C₁₉H₁₉N₇O₆),
AND
In the Calculate statement in Niacin or Niacinamide, Pyridoxine Hydrochloride, Riboflavin, and Thiamine, Method 3/Analysis: Delete
, calcium pantothenate (C₁₈H₃₂CaN₂O₁₀), and folic acid (C₁₉H₁₉N₇O₆),
AND
In the Calculate statement in Folic Acid, Method 3; Ascorbic Acid, Niacin or Niacinamide, Pyridoxine Hydrochloride, Calcium Pantothenate, Riboflavin, and Thiamine, Method 4/Analysis: Add
ascorbic acid (C₆H₈O₆)

In the Calculate statement in Niacin or Niacinamide, Pyridoxine Hydrochloride, Riboflavin, and Thiamine, Method 1/Analysis: Delete
, calcium pantothenate (C₁₈H₃₂CaN₂O₁₀), and folic acid (C₁₉H₁₉N₇O₆),
AND
In the Calculate statement in Niacin or Niacinamide, Pyridoxine Hydrochloride, Riboflavin, and Thiamine, Method 3/Analysis: Delete
, calcium pantothenate (C₁₈H₃₂CaN₂O₁₀), and folic acid (C₁₉H₁₉N₇O₆),
AND
In the Calculate statement in Folic Acid Method 3; Ascorbic Acid, Niacin or Niacinamide, Pyridoxine Hydrochloride, Calcium Pantothenate, Riboflavin, and Thiamine, Method 4/Analysis: Add
ascorbic acid (C₆H₈O₆),
AND
In Molybdenum, Method 2/Instrumental conditions: Change
(See Atomic Absorption Spectroscopy <852>.)
to:
(See Ultraviolet-Visible Spectroscopy <857>.)

In Vitamins B3 (as Niacinamide), B6, and Folic Acid, Method 1/System suitability: Change
[Note—The relative retention times for niacinamide, pyridoxine, and folic acid are about 1.0, 1.6, 2.0, and 3.0 respectively.]
to:
[Note—The relative retention times for niacinamide, pyridoxine, and folic acid are about 1.0, 2.0, and 3.0, respectively.]
AND
In Vitamins B1 (as Thiamine Ion) and B2 (as Riboflavin), Method 1; Vitamin C (as Ascorbic Acid), Vitamins B3 (as Niacinamide), B6 (as Pyridoxine), and Folic Acid, Method 2/Analysis: Change
Calculate the percentage of the labeled amount of vitamin B1 as thiamine ion (C₁₂H₁₇N₄OS⁺), vitamin B2 as riboflavin (C₁₇H₂₀N₄O₆), vitamin B3 as niacinamide (C₆H₆N₂O), vitamin B6 as pyridoxine (C₈H₁₁NO₃), and folic acid (C₁₉H₁₉N₇O₆), in the portion of Chewable Gels taken:
to:
Calculate the percentage of the labeled amount of vitamin C as ascorbic acid (C₆H₈O₆), vitamin B1 as thiamine ion (C₁₂H₁₇N₄OS⁺), vitamin B2 as riboflavin (C₁₇H₂₀N₄O₆), vitamin B3 as niacinamide (C₆H₆N₂O), vitamin B6 as pyridoxine (C₈H₁₁NO₃), and folic acid (C₁₉H₁₉N₇O₆), in the portion of Chewable Gels taken:
AND
In Vitamins B1 (as Thiamine Ion) and B2 (as Riboflavin), Method 1; Vitamin C (as Ascorbic Acid), Vitamins B3 (as Niacinamide), B6 (as Pyridoxine), and Folic Acid, Method 2/Acceptance criteria: Change
90.0%–150.0% of the labeled amounts of vitamin B3 as niacinamide, vitamin B6 as pyridoxine, riboflavin, and thiamine as thiamine ion (C₁₂H₁₇N₄OS⁺); and NLT 90.0% and NMT 245.0% of the labeled amount of folic acid
to:
90.0%–250.0% of the labeled amount of vitamin C as ascorbic acid; 90.0%–150.0% of the labeled amounts of vitamin B3 as niacinamide, vitamin B6 as pyridoxine, riboflavin, and thiamine as thiamine ion (C₁₂H₁₇N₄OS⁺); and NLT 90.0% and NMT 245.0% of the labeled amount of folic acid

Line 1 of Vitamin A, Method 1/Sample solution: Change
Sample solution
to:
Sample stock solution
AND
Line 23 of Sample solution: Change
Dilute a volume of this solution
to:
Sample solution: Dilute a volume of the Sample stock solution
AND
Line 1 of Cholecalciferol or Ergocalciferol (Vitamin D), Method 1/Sample solution:Change
Proceed as directed for the Sample solution
to:
Proceed as directed for the Sample stock solution
AND
Line 1 of Vitamin E, Method 1/Sample solution: Change
Proceed as directed for the Sample solution
to:
Proceed as directed for the Sample stock solution
AND
Line 1 of Phytonadione/Sample solution:Change
Proceed as directed for the Sample solution
to:
Proceed as directed for the Sample stock solution

In Biotin, Method 3/Solid-phase extraction: Change
anion-xchange
to:
anion-exchange
AND
In the Calculate statement in Niacin or Niacinamide, Pyridoxine Hydrochloride, Riboflavin, and Thiamine, Method 1/Analysis: Delete
, calcium pantothenate (C₁₈H₃₂CaN₂O₁₀), and folic acid (C₁₉H₁₉N₇O₆),
AND
In the Calculate statement in Niacin or Niacinamide, Pyridoxine Hydrochloride, Riboflavin, and Thiamine, Method 3/Analysis: Delete
, calcium pantothenate (C₁₈H₃₂CaN₂O₁₀), and folic acid (C₁₉H₁₉N₇O₆),
AND
In the Calculate statement in Folic Acid, Method 3; Ascorbic Acid, Niacin or Niacinamide, Pyridoxine Hydrochloride, Calcium Pantothenate, Riboflavin, and Thiamine, Method 4/Analysis: Add
ascorbic acid (C₆H₈O₆),

Line 1 of Vitamin A, Method 1/Sample solution: Change
Sample solution
to:
Sample stock solution
AND
Line 16 of Sample solution: Change
Dilute a 10-mL volume of this solution
to:
Sample solution: Dilute a 10-mL volume of the Sample stock solution
AND
Line 2 of Cholecalciferol or Ergocalciferol (Vitamin D), Method 1/Sample solution: Change
Proceed as directed for the Sample solution
to:
Proceed as directed for the Sample stock solution
AND
Line 1 of Vitamin E, Method 1/Sample solution: Change
Proceed as directed for the Sample solution
to:
Proceed as directed for the Sample stock solution
AND
Line 2 of Phytonadione, Method 1/Sample solution: Change
retained as specified in the directions for Sample solution
to:
retained as specified in the directions for Sample stock solution

In the Calculate statement in Niacin or Niacinamide, Pyridoxine Hydrochloride, Riboflavin, and Thiamine, Method 1/Analysis: Delete
, calcium pantothenate (C₁₈H₃₂CaN₂O₁₀), and folic acid (C₁₉H₁₉N₇O₆),
AND
In the Calculate statement in Niacin or Niacinamide, Pyridoxine Hydrochloride, Riboflavin, and Thiamine, Method 3/Analysis: Delete
, calcium pantothenate (C₁₈H₃₂CaN₂O₁₀), and folic acid (C₁₉H₁₉N₇O₆),
AND
In the Calculate statement in Folic Acid, Method 3; Ascorbic Acid, Niacin or Niacinamide, Pyridoxine Hydrochloride, Calcium Pantothenate, Riboflavin, and Thiamine, Method 4/Analysis: Add
ascorbic acid (C₆H₈O₆),

Line 1 of Vitamin A/Sample solution: Change
Sample solution
to:
Sample stock solution
AND
Line 21 of Sample solution: Change
Further dilute this solution
to:
Sample solution: Dilute the Sample stock solution
AND
Line 2 of Vitamin D/Sample solution: Change
as directed for the Sample solution
to:
as directed for the Sample stock solution
AND
Line 2 of Vitamin E/Sample solution: Change
prepared as directed for the Sample solution
to:
prepared as directed for the Sample stock solution
AND
Line 2 of Phytonadione (Vitamin K₁):Change
as directed for the Sample solution
to:
as directed for the Sample stock solution
AND
Line 2 of Beta Carotene/Sample solution: Change
as directed for the Sample solution
to:
as directed for the Sample stock solution

In Vitamin A, Method 3/Analysis: Change
C_S = concentration of retinyl acetate (C₂₃H₃₂O₂) from USP Vitamin A RS in the Standard solution (μg/mL)
to:
C_S = concentration of retinyl acetate (C₂₂H₃₂O₂) from USP Vitamin A RS in the Standard solution (μg/mL)

Line 1 of Vitamin A/Sample solution: Change
Sample solution
to:
Sample stock solution
AND
Line 15 of Sample solution: Change
Further dilute this solution
to:
Sample solution: Dilute the Sample stock solution
AND
Line 2 of Vitamin D/Sample solution: Change
as directed for the Sample solution
to:
as directed for the Sample stock solution
AND
Line 2 of Vitamin E/Sample solution: Change
prepared as directed for the Sample solution
to:
prepared as directed for the Sample stock solution
AND
Line 2 of Phytonadione (Vitamin K₁):Change
as directed for the Sample solution
to:
as directed for the Sample stock solution
AND
Line 2 of Beta Carotene/Sample solution: Change
as directed for the Sample solution
to:
as directed for the Sample stock solution

In Vitamin A, Method 3/Analysis: Change
C_S = concentration of retinyl acetate (C₂₃H₃₂O₂) from USP Vitamin A RS in the Standard solution (μg/mL)
to:
C_S = concentration of retinyl acetate (C₂₂H₃₂O₂) from USP Vitamin A RS in the Standard solution (μg/mL)

In Standardization with visual end point: Change
M = mL edetate disodium × edetate disodium/mL ZnSO₄
to:
M = mL edetate disodium × M edetate disodium/mL ZnSO₄
AND
In Standardization with potentiometric end point: Change
M = mL edetate disodium × edetate disodium/mL ZnSO₄
to:
M = mL edetate disodium × M edetate disodium/mL ZnSO₄